Lindbrook Capital »

Zymeworks Del shares owned by Lindbrook Capital

Quarter-by-quarter ownership of Zymeworks Del (ZYME) shares owned by Lindbrook Capital from 13F filings

Historical chart of Lindbrook Capital investment in Zymeworks Del

Tip: Access up to 7 years of quarterly data

All positions including Zymeworks Del held by Lindbrook Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zymeworks Del by Lindbrook Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $3.3k 318 10.52
2023-12-31 $3.3k 318 10.39
2023-06-30 $302 35 8.63

More positions owned by Lindbrook Capital

Vanguard Total Stk Mkt Etf (VTI)
Vanguard Total Intl Stock Idex Etf Etf (VXUS)
Golub Cap Bdc Cef (GBDC)
Apple Stock (AAPL)
Spdr S&p 500 Etf Trust Etf (SPY)
Ishares Russell 1000 Growth Etf Etf (IWF)
Nvidia Corporation Stock (NVDA)
Microsoft Stock (MSFT)
Rpar Risk Parity Etf Etf (RPAR)
Ishares Russell 1000 Value Etf Etf (IWD)
Amazon.com Stock (AMZN)
Powershares Qqq Tr Etf (QQQ)
Oaktree Specialty Lending Corp Cef (OCSL)
Vertex Pharmaceuticals In Stock (VRTX)
Broadcom Stock (AVGO)

View all positions for Lindbrook Capital

Top funds holding Zymeworks Del

EcoR1 Capital
BVF
Redmile Group
Vanguard Group
Credit Suisse
Bnp Paribas Investment Partners
Samsara BioCapital
Tang Capital Management
Perceptive Advisors
Deutsche Bank Aktiengesellschaft
AQR Capital Management
Jupiter Asset Management
Jacobs Levy Equity Management
Arrowstreet Capital, Limited Partnership
Picton Mahoney Asset Management

View all funds holding Zymeworks Del